Among other matters Dieter Gericke’s assignments included advising ChemChina in the public takeover of Syngenta, EF in the sale of its China kids business, Therachon in the sale to Pfizer, Meyer Burger in a proxy fight and capital increase, Bregal in the acquisition of Kunststoff Schwanden, Bühler in the acquisition of Haas Group, Givaudan in the acquisition of Induchem, Infront Sports & Media in the sale to Dalian Wanda, Nestlé in the sale of Alcon to Novartis, Kering in the acquisition of Ulysse Nardin or SCOR in the unsolicited takeover of Converium. He advised on numerous IPOs, including ADC Therapeutics, Zur Rose Group, AC Immune, Endosense, Kuros Biosurgery, Molecular Partners, Gategroup, Santhera, BioXell or tamedia. He has long-standing experience in assisting boards of directors and managements of public and private companies in corporate governance matters and specific challenges like shareholder activism and -claims, proxy-fights, securities regulations, reorganizations and directors’ & officers’ liability. Dieter Gericke has a particularly strong foothold in the life sciences, chemicals, engineering and technology as well as insurance industries.

Dieter Gericke is a member of the Corporate and M&A Committee and the Securities Law Committee of the International Bar Association.
Dieter Gericke has chaired or been a speaker at numerous conferences with recent speaking topics including M&A. shareholder activism, proxy advisors, private equity, negotiation tactics, takeover laws or joint ventures.

In his areas of practice Dieter Gericke authored various publications and legal opinions, including on mergers & acquisitions, securities laws, directors’ and officers’ duties and liability and corporate governance.Dieter Gericke joined Homburger as an associate in 2000 and has been partner since 2004 and head of the Corporate M&A practice team since 2014. Since 2010, he also heads the Homburger China Group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LL.M. In addition, Dieter Gericke studied one semester at Université de Paris II (Assas).

Dieter Gericke has been a member of the boards of directors of Syngenta AG and, since many years, of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries. In addition he is serving in honorary capacity as a member of the board of supervisors of Theater an der Winkelwiese, Zurich and of the Harvard Club of Switzerland.